RESUMO
BACKGROUND: Men die earlier than women in Germany. Men also have impaired access to cancer screening compared to women. OBJECTIVES: Our Movember campaign 2019 at University Hospital Frankfurt (UKF) aimed at improving health care awareness in the context of prostate cancer checkup. MATERIALS AND METHODS: In November 2019, every male employee of the UKF with a minimum age of 45 yrs (or 40 yrs with a first degree relative with prostate cancer) was offered a free prostate cancer checkup. This checkup contained digital rectal examination (DRE), transrectal ultrasound and PSA (prostata-specific antigen) testing. RESULTS: Overall, 121/840 employees (14.4%) participated in the Movember campaign. A first degree relative with prostate cancer was reported in overall by 14% of the participants (nâ¯=â¯17). At least one prior prostate cancer check up had 33%. A total of 2.5% (nâ¯=â¯3) had one prior negative prostate biopsy. Median age was 54 yrs (interquartile range 50-58). Median PSA level was 0.9â¯ng/ml and median free-PSA 0.3â¯ng/ml. A suspicious DRE was found in 5% (nâ¯=â¯6). After stratification according to age (≤â¯50 yrs vs. >â¯50 yrs), participants over 50 yrs had a significantly higher PSA level (1.0â¯ng/ml vs. 0.7â¯ng/ml, pâ¯<â¯0.01) and had more frequently at least one prior prostate cancer checkup in the past (42.0 vs. 12.1%, pâ¯<â¯0.01). All suspicious DREs were in the cohort >â¯50 yrs. Overall, 32.2% (nâ¯=â¯39) had at least a suspicious checkup. A total of 3.3% (nâ¯=â¯4) had suspicious PSA levels. 17.4% (nâ¯=â¯21) of the participants had a suspicious PSA ratio (<â¯20%) only. During follow-up, 6 prostate biopsies were performed, with the detection of one case of intermediate-risk prostate cancer (Gleason 3â¯+â¯4, pT3a, pPn1, pNx, R0). CONCLUSION: Overall, 121 employees participated in our Movember Prostate cancer checkup campaign with measurement of the PSA level. Suspicious results were recorded in 32.2%. One employee was diagnosed and successfully treated with an intermediate-risk prostate cancer.
